We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $646M
1-Year Est. Return 43.3%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+43.3%
3 Year Est. Return
+98.62%
5 Year Est. Return
+125.42%
10 Year Est. Return
+408.39%
AUM
$236M
AUM Growth
+$11.3M
Cap. Flow
+$2.4M
Cap. Flow %
1.02%
Top 10 Hldgs %
32.76%
Holding
119
New
6
Increased
45
Reduced
36
Closed
15

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$916K
2
ABT icon
Abbott
ABT
+$605K
3
ROK icon
Rockwell Automation
ROK
+$566K
4
XLNX
Xilinx Inc
XLNX
+$559K
5
TGT icon
Target
TGT
+$520K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$2.61M
2
ADP icon
Automatic Data Processing
ADP
+$553K
3
XOM icon
ExxonMobil
XOM
+$394K
4
DYAX
DYAX CORPORATION
DYAX
+$376K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$354K

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Healthcare 20.68%
3 Industrials 19.38%
4 Energy 10.99%
5 Consumer Staples 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB
101
DELISTED
CHUBB CORPORATION
CB
– –
-483
Closed -$44K
1 2 3 4
5

Similar funds

HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CRCM
Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return
APC
Alta Park Capital San Francisco, California $642M AUM 140.04% 1-Year Est. Return
WHGAM
Wealth High Governance Asset Management Sao Paulo $641M AUM
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Brian C. Broderick's Q4 2014 Portfolio in Review

As of Q4 2014, Brian C. Broderick held 119 positions worth $236M, up 5% from $225M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q4 2014 filing shows 6 new, 45 increased, 36 reduced and 15 closed positions. Its largest new stake was CDK Global, Inc.: 25,869 shares worth $1.05M. The largest sale was GSK, an estimated $2.61M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2014 buy was CDK Global, Inc.: 25,869 shares worth $1.05M.
  • Brian C. Broderick added most to Abbott in Q4 2014, an estimated $605K increase.
  • Brian C. Broderick's biggest Q4 2014 reduction was GSK, cutting an estimated $2.61M.
  • Brian C. Broderick fully exited Vanguard FTSE Emerging Markets ETF in Q4 2014, selling an estimated $354K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $236M portfolio in Q4 2014.
  • Brian C. Broderick opened 6 new positions and closed 15 in Q4 2014.
  • Brian C. Broderick's portfolio value rose 5% quarter-over-quarter to $236M.

Based on Brian C. Broderick's 13F filing for Q4 2014, filed 13 Feb 2015.